Bristol-Myers Squibb
BMY
#182
Rank
HK$928.40 B
Marketcap
HK$454.71
Share price
-0.39%
Change (1 day)
22.53%
Change (1 year)

Market capitalization of Bristol-Myers Squibb (BMY)

Market cap: HK$928.40 Billion

As of April 2026 Bristol-Myers Squibb has a market cap of HK$928.40 Billion. This makes Bristol-Myers Squibb the world's 182th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Bristol-Myers Squibb from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$928.40 B7.27%
2025HK$865.47 B-4.71%
2024HK$908.21 B11.38%
2023HK$815.39 B-31.78%
2022HK$1.195 T10.76%
2021HK$1.079 T-0.69%
2020HK$1.086 T-2.44%
2019HK$1.113 T68.49%
2018HK$661.04 B-15.64%
2017HK$783.61 B3.47%
2016HK$757.36 B-14.48%
2015HK$885.59 B17.01%
2014HK$756.84 B11.91%
2013HK$676.32 B64.25%
2012HK$411.75 B-11.22%
2011HK$463.80 B32.47%
2010HK$350.11 B4.64%
2009HK$334.58 B-5.93%
2008HK$355.66 B-12.86%
2007HK$408.17 B1.63%
2006HK$401.62 B15.19%
2005HK$348.68 B-10.05%
2004HK$387.64 B-9.86%
2003HK$430.06 B21.94%
2002HK$352.68 B-54.8%
2001HK$780.31 B-30.73%
2000HK$1.126 T14.05%
1999HK$987.75 B-4.19%
1998HK$1.030 T41.55%
1997HK$728.30 B72.65%
1996HK$421.83 B

End of Day market cap according to different sources

On Apr 28th, 2026 the market cap of Bristol-Myers Squibb was reported to be:

HK$932.40 Billion
by Nasdaq info icon info icon
HK$932.08 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.306 T 363.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.141 T 130.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$1.173 T 26.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$2.830 T 204.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$5.972 T 543.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.423 T 53.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$862.63 B-7.08%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$220.85 B-76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.136 T 130.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$2.241 T 141.47%๐Ÿ‡ฌ๐Ÿ‡ง UK